Closed-loop LRP Delivery Platform
Platform for targeted organ delivery (e.g., cardiac, muscular)
Pre-clinicalActive
Key Facts
Indication
Platform for targeted organ delivery (e.g., cardiac, muscular)
Phase
Pre-clinical
Status
Active
Company
About DiNAQOR
DiNAQOR is a Swiss-based life science company builder specializing in creating and scaling biotechnology ventures, with a focus on gene therapy and advanced delivery platforms. The company has established a spin-out, DiNATEQ AG, to clinically translate its proprietary closed-loop loco-regional perfusion (LRP) delivery technology. Recent strategic leadership appointments, including the CEO of Sirion Biotech, underscore its intent to build strategic partnerships and translate breakthrough technologies into clinical and commercial success.
View full company profile